Cryoport, Inc., a temperature-controlled logistics company dedicated to the life sciences industry, unveiled its newest global logistics center, based in Livingston with a ribbon-cutting ceremony attended by several of Cryoport’s clients, local dignitaries and business partners. Cryoport’s newest state-of-the-art global logistics center is located in a strategic life sciences hub and provides an important addition to Cryoport’s logistics network, which allows the Company to more effectively support its biopharma clients. Cryoport’s expanding logistics network provides Cryoport Express® services and additional biopharma compliance management options, on a global basis, supporting the development and manufacturing of the new emerging and groundbreaking regenerative therapies.
Cryoport is opening this center to meet the needs of the rapidly developing regenerative therapy market as it prepares for substantial increases in the number of clinical trials, as well as the ramping of commercial products it currently supports, by investing in its infrastructure. This new Cryoport Global Logistics Center located in Livingston adds significantly to Cryoport’s logistics network, which is built for the purpose of supporting the expected increase in demand for its logistics solutions by its global life sciences client base. Cryoport’s entire suite of temperature-controlled solutions will be offered out of the Livingston Global Logistics Center. Novartis, Celgene and bluebird bio are among the clients being supported from this new location.
Jerrell Shelton, chief executive officer of Cryoport, commented, “Many of our biopharma clients are predicting significant increases in the number of regenerative therapy clinical trials they expect to undertake. This is, in fact, a time when the industry is reaching an inflection point with a number of FDA-approved therapies now approaching the launching stage in the commercial market. Reliable and efficient management of the biopharma supply chain is critical to advancing the plans of these clients, who are developing and bringing to market the next generation of regenerative therapies, which will surely impact the practice of medicine in profound ways. To support this, reliable and efficient management of the biopharma supply chain is critical. At Cryoport, we are constantly focused on improving our competencies and providing best-in-class service to meet these needs.
“Launching our new Global Logistics Center in Livingston enables us to provide even faster service and, in some cases, same-day delivery to support our clients’ manufacturing operations, not just in the U.S. but worldwide, effectively, efficiently and safely. Our Global Logistics Centers are designed to be inherently scalable and supportive of life sciences industry needs. We expect commercial regenerative therapies to continue to ramp over time. Livingston, New Jersey is a major biotech hub with robust, large, well-established biopharmaceutical companies along with innovative startups, incubator sites and large biotech-focused research institutions, many of whom are already partnered with Cryoport for their temperature-controlled logistics requirements. This makes it an ideal location.”
To access more business news, visit NJB News Now.